Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.

Benesch M, Nemes K, Neumayer P, Hasselblatt M, Timmermann B, Bison B, Ebetsberger-Dachs G, Bourdeaut F, Dufour C, Biassoni V, Morales La Madrid A, Entz-Werle N, Laithier V, Quehenberger F, Weis S, Sumerauer D, Siebert R, Bens S, Schneppenheim R, Kool M, Modena P, Fouyssac F, C Frühwald M.

Pediatr Blood Cancer. 2019 Oct 1:e28022. doi: 10.1002/pbc.28022. [Epub ahead of print]

PMID:
31571386
2.

Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations.

König G, Obser T, Marggraf O, Schneppenheim S, Budde U, Schneppenheim R, Brehm MA.

Thromb Haemost. 2019 Jul;119(7):1102-1111. doi: 10.1055/s-0039-1687878. Epub 2019 Apr 29.

PMID:
31035301
3.

Von Willebrand Factor Mediates Pneumococcal Aggregation and Adhesion in Blood Flow.

Jagau H, Behrens IK, Lahme K, Lorz G, Köster RW, Schneppenheim R, Obser T, Brehm MA, König G, Kohler TP, Rohde M, Frank R, Tegge W, Fulde M, Hammerschmidt S, Steinert M, Bergmann S.

Front Microbiol. 2019 Mar 26;10:511. doi: 10.3389/fmicb.2019.00511. eCollection 2019.

4.

Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1.

Thomas C, Knerlich-Lukoschus F, Reinhard H, Johann PD, Sturm D, Sahm F, Bens S, Vogt J, Nemes K, Oyen F, Kordes U, Siebert R, Schneppenheim R, Messing-Jünger M, Pietsch T, von Deimling A, Paulus W, Pfister SM, Kool M, Frühwald MC, Hasselblatt M.

Acta Neuropathol. 2019 May;137(5):847-850. doi: 10.1007/s00401-019-02001-3. Epub 2019 Apr 3. No abstract available.

PMID:
30945057
5.

The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.

van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry.

Haematologica. 2019 Oct;104(10):2107-2115. doi: 10.3324/haematol.2019.216796. Epub 2019 Feb 21.

6.

Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging.

Löf A, König G, Schneppenheim S, Schneppenheim R, Benoit M, Budde U, Müller JP, Brehm MA.

PLoS One. 2019 Jan 15;14(1):e0210963. doi: 10.1371/journal.pone.0210963. eCollection 2019.

7.

Characterization of VWF gene conversions causing von Willebrand disease.

Ahmad F, Kannan M, Obser T, Budde U, Schneppenheim S, Saxena R, Schneppenheim R.

Br J Haematol. 2019 Mar;184(5):817-825. doi: 10.1111/bjh.15709. Epub 2018 Nov 29.

PMID:
30488424
8.

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.

Schneppenheim R, Hellermann N, Brehm MA, Klemm U, Obser T, Huck V, Schneider SW, Denis CV, Tischer A, Auton M, März W, Xu ER, Wilmanns M, Zotz RB.

Blood. 2019 Jan 24;133(4):356-365. doi: 10.1182/blood-2018-04-843425. Epub 2018 Oct 26.

PMID:
30366922
9.

Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.

Xu ER, von Bülow S, Chen PC, Lenting PJ, Kolšek K, Aponte-Santamaría C, Simon B, Foot J, Obser T, Schneppenheim R, Gräter F, Denis CV, Wilmanns M, Hennig J.

Blood. 2019 Jan 24;133(4):366-376. doi: 10.1182/blood-2018-04-843615. Epub 2018 Oct 10.

10.

Supplementary Therapeutic Recommendations.

Hassenpflug WA, Schneppenheim R.

Dtsch Arztebl Int. 2018 Sep 14;155(37):608. doi: 10.3238/arztebl.2018.0608a. No abstract available.

11.

Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy.

Nicolay JP, Thorn V, Daniel C, Amann K, Siraskar B, Lang F, Hillgruber C, Goerge T, Hoffmann S, Gorzelanny C, Huck V, Mess C, Obser T, Schneppenheim R, Fleming I, Schneider MF, Schneider SW.

Sci Rep. 2018 Jul 19;8(1):10945. doi: 10.1038/s41598-018-28961-2.

12.

An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study.

Szederjesi A, Baronciani L, Budde U, Castaman G, Lawrie AS, Liu Y, Montgomery R, Peyvandi F, Schneppenheim R, Várkonyi A, Patzke J, Bodó I.

J Thromb Haemost. 2018 Jun 13. doi: 10.1111/jth.14206. [Epub ahead of print]

PMID:
29897666
13.

Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1.

Kehrer-Sawatzki H, Kordes U, Seiffert S, Summerer A, Hagel C, Schüller U, Farschtschi S, Schneppenheim R, Bendszus M, Godel T, Mautner VF.

Mol Genet Genomic Med. 2018 May 20. doi: 10.1002/mgg3.412. [Epub ahead of print]

14.

Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.

Holsten T, Bens S, Oyen F, Nemes K, Hasselblatt M, Kordes U, Siebert R, Frühwald MC, Schneppenheim R, Schüller U.

Eur J Hum Genet. 2018 Aug;26(8):1083-1093. doi: 10.1038/s41431-018-0143-1. Epub 2018 Apr 30. Review.

15.

Interaction of von Willebrand factor domains with collagen investigated by single molecule force spectroscopy.

Posch S, Obser T, König G, Schneppenheim R, Tampé R, Hinterdorfer P.

J Chem Phys. 2018 Mar 28;148(12):123310. doi: 10.1063/1.5007313.

PMID:
29604837
16.

Genetic and Functional Characterization of ADAMTS13 Variants in a Patient Cohort with Upshaw-Schulman Syndrome Investigated in Germany.

Hassenpflug WA, Obser T, Bode J, Oyen F, Budde U, Schneppenheim S, Schneppenheim R, Brehm MA.

Thromb Haemost. 2018 Apr;118(4):709-722. doi: 10.1055/s-0038-1637749. Epub 2018 Mar 19.

PMID:
29554699
17.

The extraordinary challenge of treating patients with congenital rhabdoid tumors-a collaborative European effort.

Nemes K, Clément N, Kachanov D, Bens S, Hasselblatt M, Timmermann B, Schneppenheim R, Gerss J, Siebert R, Furtwängler R, Bourdeaut F, Frühwald MC; EU-RHAB consortium.

Pediatr Blood Cancer. 2018 Jun;65(6):e26999. doi: 10.1002/pbc.26999. Epub 2018 Feb 8.

PMID:
29418059
18.

Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.

Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, Reis GF, Nobusawa S, Arita K, Felsberg J, Reifenberger G, Agaimy A, Buslei R, Capper D, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Paulus W, Kool M, Hasselblatt M.

Am J Surg Pathol. 2018 Apr;42(4):506-511. doi: 10.1097/PAS.0000000000001023.

PMID:
29324471
19.

Rhabdoid Tumor Predisposition Syndrome.

Nemes K, Bens S, Bourdeaut F, Hasselblatt M, Kool M, Johann P, Kordes U, Schneppenheim R, Siebert R, Frühwald MC.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2017 Dec 7.

20.

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.

Scully M, Knöbl P, Kentouche K, Rice L, Windyga J, Schneppenheim R, Kremer Hovinga JA, Kajiwara M, Fujimura Y, Maggiore C, Doralt J, Hibbard C, Martell L, Ewenstein B.

Blood. 2017 Nov 9;130(19):2055-2063. doi: 10.1182/blood-2017-06-788026. Epub 2017 Sep 14.

21.

Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.

Tischer A, Machha VR, Frontroth JP, Brehm MA, Obser T, Schneppenheim R, Mayne L, Walter Englander S, Auton M.

J Mol Biol. 2017 Jul 7;429(14):2161-2177. doi: 10.1016/j.jmb.2017.05.013. Epub 2017 May 19.

22.

Glial papillary tumour of the spinal cord with SMARCB1/INI1-loss and favourable long-term outcome.

Hasselblatt M, Kurniawan AD, Rozsnoki S, Johann PD, Bens S, Oyen F, Schneppenheim R, Siebert R, Capper D, Kool M, Schul C, Paulus W.

Neuropathol Appl Neurobiol. 2018 Feb;44(2):229-232. doi: 10.1111/nan.12395. No abstract available.

PMID:
28218953
23.

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.

Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP.

Am J Med Genet A. 2017 Apr;173(4):1017-1037. doi: 10.1002/ajmg.a.38142. Epub 2017 Feb 7. Review.

PMID:
28168833
24.

Mutation G1629E Increases von Willebrand Factor Cleavage via a Cooperative Destabilization Mechanism.

Aponte-Santamaría C, Lippok S, Mittag JJ, Obser T, Schneppenheim R, Baldauf C, Gräter F, Budde U, Rädler JO.

Biophys J. 2017 Jan 10;112(1):57-65. doi: 10.1016/j.bpj.2016.11.3202.

25.

Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.

Stahn V, Nagel I, Fischer-Huchzermeyer S, Oyen F, Schneppenheim R, Gesk S, Bohring A, Chikobava L, Young P, Gess B, Werner M, Senner V, Harder A.

Am J Pathol. 2016 Dec;186(12):3285-3296. doi: 10.1016/j.ajpath.2016.08.019. Epub 2016 Oct 17.

PMID:
27765635
26.

Single molecule force spectroscopy data and BD- and MD simulations on the blood protein von Willebrand factor.

Posch S, Aponte-Santamaría C, Schwarzl R, Karner A, Radtke M, Gräter F, Obser T, König G, Brehm MA, Gruber HJ, Netz RR, Baldauf C, Schneppenheim R, Tampé R, Hinterdorfer P.

Data Brief. 2016 Jul 21;8:1080-7. doi: 10.1016/j.dib.2016.07.031. eCollection 2016 Sep.

27.

Atypical teratoid/rhabdoid tumor arising in a malignant glioma.

Bozzai B, Hasselblatt M, Turányi E, Frühwald MC, Siebert R, Bens S, Schneppenheim R, Kool M, Stelczer G, Hortobágyi T, Hauser P.

Pediatr Blood Cancer. 2017 Jan;64(1):96-99. doi: 10.1002/pbc.26173. Epub 2016 Jul 29.

PMID:
27472468
28.

pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor.

Müller JP, Löf A, Mielke S, Obser T, Bruetzel LK, Vanderlinden W, Lipfert J, Schneppenheim R, Benoit M.

Biophys J. 2016 Jul 26;111(2):312-322. doi: 10.1016/j.bpj.2016.06.022.

29.

Inherited Thrombotic Thrombocytopenic Purpura (Upshaw Schulman Syndrome) as Differential Diagnosis to Neonatal Septicaemia with Disseminated Intravascular Coagulation - a Case Series.

Lehmberg K, Hassenpflug WA, Klaassen I, Hillebrand G, Oyen F, Budde U, Singer D, Schneppenheim R.

Z Geburtshilfe Neonatol. 2017 Feb;221(1):39-42. doi: 10.1055/s-0042-109404. Epub 2016 Jul 6.

PMID:
27383044
30.

Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.

Johann PD, Hovestadt V, Thomas C, Jeibmann A, Heß K, Bens S, Oyen F, Hawkins C, Pierson CR, Aldape K, Kim SP, Widing E, Sumerauer D, Hauser P, van Landeghem F, Ryzhova M, Korshunov A, Capper D, Jones DTW, Pfister SM, Schneppenheim R, Siebert R, Paulus W, Frühwald MC, Kool M, Hasselblatt M.

Brain Pathol. 2017 Jul;27(4):411-418. doi: 10.1111/bpa.12413. Epub 2016 Aug 11.

PMID:
27380723
31.

Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?

Vokuhl C, Oyen F, Häberle B, von Schweinitz D, Schneppenheim R, Leuschner I.

Genes Chromosomes Cancer. 2016 Dec;55(12):925-931. doi: 10.1002/gcc.22390. Epub 2016 Jul 29.

PMID:
27356182
32.

Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.

Obser T, Ledford-Kraemer M, Oyen F, Brehm MA, Denis CV, Marschalek R, Montgomery RR, Sadler JE, Schneppenheim S, Budde U, Schneppenheim R.

J Thromb Haemost. 2016 Sep;14(9):1725-35. doi: 10.1111/jth.13398. Epub 2016 Aug 20.

33.

Von Willebrand factor regulates complement on endothelial cells.

Noone DG, Riedl M, Pluthero FG, Bowman ML, Liszewski MK, Lu L, Quan Y, Balgobin S, Schneppenheim R, Schneppenheim S, Budde U, James P, Atkinson JP, Palaniyar N, Kahr WH, Licht C.

Kidney Int. 2016 Jul;90(1):123-34. doi: 10.1016/j.kint.2016.03.023. Epub 2016 May 25.

34.

Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.

Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Dürken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Frühwald MC.

Cancer Med. 2016 Aug;5(8):1765-75. doi: 10.1002/cam4.741. Epub 2016 May 26.

35.

Mutual A domain interactions in the force sensing protein von Willebrand factor.

Posch S, Aponte-Santamaría C, Schwarzl R, Karner A, Radtke M, Gräter F, Obser T, König G, Brehm MA, Gruber HJ, Netz RR, Baldauf C, Schneppenheim R, Tampé R, Hinterdorfer P.

J Struct Biol. 2017 Jan;197(1):57-64. doi: 10.1016/j.jsb.2016.04.012. Epub 2016 Apr 23.

36.

Rapid Diagnosis of an AT/RT by the Detection of a Heterozygous SMARCB1 Germ Line Deletion in an Infant.

Kerl K, Oyen F, Giannikopoulou D, Rössig C, Rellensmann G, Sandkötter J, Brentrup A, Selzer G, Schneppenheim R, Frühwald MC.

Pediatr Blood Cancer. 2016 Aug;63(8):1451-3. doi: 10.1002/pbc.25996. Epub 2016 Apr 19.

PMID:
27092963
37.

Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.

Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Vogel H, Riemenschneider MJ, Antonelli M, Giangaspero F, Bernardo MC, Giannini C, Ud Din N, Perry A, Keyvani K, van Landeghem F, Sumerauer D, Hauser P, Capper D, Korshunov A, Jones DT, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Kool M.

Acta Neuropathol. 2016 Jul;132(1):149-51. doi: 10.1007/s00401-016-1574-9. Epub 2016 Apr 11. No abstract available.

PMID:
27067307
38.

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.

Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DTW, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, Bens S, Gröschel S, Kratochwil F, Wittmann A, Sieber L, Geörg C, Wolf S, Beck K, Oyen F, Capper D, van Sluis P, Volckmann R, Koster J, Versteeg R, von Deimling A, Milde T, Witt O, Kulozik AE, Ebinger M, Shalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Jabado N, Taylor MD, Huang A, Aronica E, Bertoni A, Radlwimmer B, Pietsch T, Schüller U, Schneppenheim R, Northcott PA, Korbel JO, Siebert R, Frühwald MC, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister SM, Kool M.

Cancer Cell. 2016 Mar 14;29(3):379-393. doi: 10.1016/j.ccell.2016.02.001. Epub 2016 Feb 25.

39.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren AO, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M.

Cell. 2016 Feb 25;164(5):1060-1072. doi: 10.1016/j.cell.2016.01.015.

40.

Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

Lippok S, Radtke M, Obser T, Kleemeier L, Schneppenheim R, Budde U, Netz RR, Rädler JO.

Biophys J. 2016 Feb 2;110(3):545-554. doi: 10.1016/j.bpj.2015.12.023.

41.

Force sensing by the vascular protein von Willebrand factor is tuned by a strong intermonomer interaction.

Müller JP, Mielke S, Löf A, Obser T, Beer C, Bruetzel LK, Pippig DA, Vanderlinden W, Lipfert J, Schneppenheim R, Benoit M.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1208-13. doi: 10.1073/pnas.1516214113. Epub 2016 Jan 19.

42.

Long-term survival of an infant with an atypical teratoid/rhabdoid tumor following subtotal resection and low-cumulative dose chemotherapy: a case report.

Arnhold V, Oyen F, Schneppenheim R, Haberl H, Koch A, Frühwald MC, Hernáiz Driever P.

Childs Nerv Syst. 2016 Jun;32(6):1157-61. doi: 10.1007/s00381-015-2999-5. Epub 2016 Jan 8.

PMID:
26747622
43.

von Willebrand factor is dimerized by protein disulfide isomerase.

Lippok S, Kolšek K, Löf A, Eggert D, Vanderlinden W, Müller JP, König G, Obser T, Röhrs K, Schneppenheim S, Budde U, Baldauf C, Aponte-Santamaría C, Gräter F, Schneppenheim R, Rädler JO, Brehm MA.

Blood. 2016 Mar 3;127(9):1183-91. doi: 10.1182/blood-2015-04-641902. Epub 2015 Dec 15.

PMID:
26670633
44.

Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease.

Stockley J, Nisar SP, Leo VC, Sabi E, Cunningham MR, Eikenboom JC, Lethagen S, Schneppenheim R, Goodeve AC, Watson SP, Mundell SJ, Daly ME; GAPP Study in Collaboration with the MCMDM-1VWD Study Group.

PLoS One. 2015 Dec 2;10(12):e0143913. doi: 10.1371/journal.pone.0143913. eCollection 2015.

45.

Delayed Diagnosis of Platelet-type von Willebrand Disease in a 72-year-old Lady.

Maurer M, Mesters R, Schneppenheim R, Streif W.

Klin Padiatr. 2015 May;227(3):171-2. doi: 10.1055/s-0035-1548915. Epub 2015 May 18. No abstract available.

PMID:
25985451
46.

Platelet-type von Willebrand Disease: Diagnostic Challenges. Flaws and Pitfalls Experienced in the THROMKID Quality Project.

Maurer M, Mesters R, Schneppenheim R, Knoefler R, Streif W.

Klin Padiatr. 2015 May;227(3):131-6. doi: 10.1055/s-0035-1548838. Epub 2015 May 18. Review.

PMID:
25985448
47.

Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactions.

Aponte-Santamaría C, Huck V, Posch S, Bronowska AK, Grässle S, Brehm MA, Obser T, Schneppenheim R, Hinterdorfer P, Schneider SW, Baldauf C, Gräter F.

Biophys J. 2015 May 5;108(9):2312-21. doi: 10.1016/j.bpj.2015.03.041.

48.

Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.

Bodó I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J; von Willebrand factor Subcommittee of the Standardization and Scientific Committee of the International Society for Thrombosis and Haemostasis.

J Thromb Haemost. 2015 Jul;13(7):1345-50. doi: 10.1111/jth.12964. Epub 2015 May 9. Review. No abstract available.

49.

Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.

Lehnhardt A, Karnatz C, Ahlenstiel-Grunow T, Benz K, Benz MR, Budde K, Büscher AK, Fehr T, Feldkötter M, Graf N, Höcker B, Jungraithmayr T, Klaus G, Koehler B, Konrad M, Kranz B, Montoya CR, Müller D, Neuhaus TJ, Oh J, Pape L, Pohl M, Royer-Pokora B, Querfeld U, Schneppenheim R, Staude H, Spartà G, Timmermann K, Wilkening F, Wygoda S, Bergmann C, Kemper MJ.

Clin J Am Soc Nephrol. 2015 May 7;10(5):825-31. doi: 10.2215/CJN.10141014. Epub 2015 Mar 27.

50.

Risk of Rotavirus Vaccination for Children with SCID.

Klinkenberg D, Blohm M, Hoehne M, Mas Marques A, Malecki M, Schildgen V, Schneppenheim R, Müller I, Schildgen O, Kobbe R.

Pediatr Infect Dis J. 2015 Jan;34(1):114-5. doi: 10.1097/INF.0000000000000507. No abstract available.

PMID:
25741807

Supplemental Content

Loading ...
Support Center